Christina Takke

Oprichter bij

V-Bio Ventures BV

56 jaar

Connecties 42

Health Technology

Finance

Consumer Services

Profiel

Christina Takke is the founder and the Managing Partner of V-Bio Ventures BV, which was founded in 2015.
She is currently the Director at Confo Therapeutics NV, Precirix NV, Syndesi Therapeutics SA, and V-Bio Management 1 BV.
Dr. Takke was also a former Director at Roche Glycart AG, Amakem NV, and Pieris Pharmaceuticals, Inc. She served as an Independent Director at Pieris AG and was a Member-Supervisory Board at Polpharma Biologics Utrecht BV.
From 2013 to 2015, she was a Partner at Forbion Capital Partners Management Holding BV.
Dr. Takke also served as a Member-Supervisory Board at argenx SE.
She holds a graduate degree from Technische Universität Darmstadt and a doctorate degree from Universität zu Köln, which was conferred in 1998.

Actieve functies van Christina Takke

Bedrijven	Functie	Begin
V-Bio Ventures BV V-Bio Ventures BV Investment ManagersFinance V-Bio Ventures invests in companies located in Europe and beyond. The firm focuses on sectors such as therapeutics, including both drug discovery and drug development. It participates in early stage capital requirements.	Oprichter	28-10-2015
Precirix NV Precirix NV Pharmaceuticals: MajorHealth Technology Develops radiopharmaceuticals for cancer treatment	Directeur/Bestuurslid	01-11-2018
Confo Therapeutics NV Confo Therapeutics NV Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products	Directeur/Bestuurslid	-
V-Bio Management 1 BV V-Bio Management 1 BV Financial ConglomeratesFinance Functions as an investment holding company	Directeur/Bestuurslid	28-10-2015
Syndesi Therapeutics SA Syndesi Therapeutics SA BiotechnologyHealth Technology Develops treatments for CNS disorders	Directeur/Bestuurslid	-

Alle actieve functies van Christina Takke

Eerdere bekende functies van Christina Takke

Bedrijven	Functie	Einde
Forbion Capital Partners Management Holding BV Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion is an active manager invest companies located in Northwest Europe and the United States. The firm focuses on companies operating in the fields of life sciences and biomedical technology. It participates in early stage capital requirements with an investment size ranging from EUR 1 - 7 million. It participates in follow-on investments, takes a board seat and acts as lead investor.	Private Equity Investor	31-12-2015
Roche Glycart AG Roche Glycart AG Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that engages in research, development and commercialization of antibody-based products	Directeur/Bestuurslid	-
PIERIS PHARMACEUTICALS	Directeur/Bestuurslid	-
Amakem NV Amakem NV Medical/Nursing ServicesHealth Services Operates as a clinical stage ophthalmology company that provides treatments for serious eye conditions	Directeur/Bestuurslid	-
░░░░░░ ░░	░░░░░░░░░░░░░░░░░░░░░	-

Ervaring van Christina Takke in detail bekijken

Opleiding van Christina Takke

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Christina Takke in detail bekijken

Connecties

Eerstegraads connecties

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Bedrijven in privébezit	14
Universität zu Köln Universität zu Köln Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Technische Universität Darmstadt Technische Universität Darmstadt Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Pieris AG Pieris AG BiotechnologyHealth Technology Develops and markets an Anticalin-brand protein technology	Health Technology
Roche Glycart AG Roche Glycart AG Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that engages in research, development and commercialization of antibody-based products	Health Technology
Polpharma Biologics Utrecht BV Polpharma Biologics Utrecht BV Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical research and development company	Commercial Services
Forbion Capital Partners Management Holding BV Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion is an active manager invest companies located in Northwest Europe and the United States. The firm focuses on companies operating in the fields of life sciences and biomedical technology. It participates in early stage capital requirements with an investment size ranging from EUR 1 - 7 million. It participates in follow-on investments, takes a board seat and acts as lead investor.	Finance
argenx SE argenx SE BiotechnologyHealth Technology Develops therapies and medicines for the treatment of autoimmune diseases	Health Technology
Amakem NV Amakem NV Medical/Nursing ServicesHealth Services Operates as a clinical stage ophthalmology company that provides treatments for serious eye conditions	Health Services
Pieris Pharmaceuticals, Inc. Pieris Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and markets an anticalin-brand protein technology	Health Technology
V-Bio Ventures BV V-Bio Ventures BV Investment ManagersFinance V-Bio Ventures invests in companies located in Europe and beyond. The firm focuses on sectors such as therapeutics, including both drug discovery and drug development. It participates in early stage capital requirements.	Finance
Confo Therapeutics NV Confo Therapeutics NV Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products	Health Technology
Precirix NV Precirix NV Pharmaceuticals: MajorHealth Technology Develops radiopharmaceuticals for cancer treatment	Health Technology
Syndesi Therapeutics SA Syndesi Therapeutics SA BiotechnologyHealth Technology Develops treatments for CNS disorders	Health Technology
V-Bio Management 1 BV V-Bio Management 1 BV Financial ConglomeratesFinance Functions as an investment holding company	Finance